We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Vir Biotechnology
VIR
$1.49B
| $12.5M | ﹤0.01% |
493,722
-72,659
| -13% | -$1.78M |
|
1327
UiPath
PATH
$7.8B
| $12.4M | ﹤0.01% |
978,832
-620
| -0.1% | -$7.66K |
|
1328
ManpowerGroup
MAN
$2.63B
| $12.4M | ﹤0.01% |
149,374
-29,988
| -17% | -$2.41M |
|
|
HTO
1329
H2O America
HTO
$2.62B
| $12.4M | ﹤0.01% |
153,012
+8,580
| +6% | +$613K |
|
|
BZUN
1330
Baozun
BZUN
$172M
| $12.4M | ﹤0.01% |
2,340,659
+91,104
| +4% | +$435K |
|
1331
First Bancorp
FBP
$4.38B
| $12.4M | ﹤0.01% |
973,333
-223,075
| -19% | -$3.26M |
|
1332
Highwoods Properties
HIW
$3.47B
| $12.4M | ﹤0.01% |
442,428
-170,025
| -28% | -$4.73M |
|
1333
Teva Pharmaceuticals
TEVA
$41.2B
| $12.4M | ﹤0.01% |
1,355,110
-226,154
| -14% | -$1.97M |
|
1334
QuidelOrtho
QDEL
$838M
| $12.3M | ﹤0.01% |
143,872
+316
| +0.2% | +$26.8K |
|
1335
Vaxcyte
PCVX
$8.64B
| $12.3M | ﹤0.01% |
256,376
+66,864
| +35% | +$2.62M |
|
|
SAVE
1336
DELISTED
Spirit Airlines, Inc.
SAVE
| $12.3M | ﹤0.01% |
630,130
-53,739
| -8% | -$1.1M |
|
|
NVEE
1337
DELISTED
NV5 Global
NVEE
| $12.2M | ﹤0.01% |
370,292
-8,948
| -2% | -$311K |
|
1338
Ionis Pharmaceuticals
IONS
$9.4B
| $12.2M | ﹤0.01% |
323,178
-16,106
| -5% | -$677K |
|
1339
Euronet Worldwide
EEFT
$2.7B
| $12.1M | ﹤0.01% |
128,624
+4,162
| +3% | +$360K |
|
1340
National Vision
EYE
$1.81B
| $12.1M | ﹤0.01% |
312,985
-32,352
| -9% | -$1.21M |
|
1341
Teladoc Health
TDOC
$1.3B
| $12.1M | ﹤0.01% |
512,920
+107,367
| +26% | +$2.89M |
|
1342
Cable One
CABO
$212M
| $12.1M | ﹤0.01% |
17,039
-5,108
| -23% | -$3.81M |
|
1343
Oshkosh
OSK
$9.59B
| $12.1M | ﹤0.01% |
137,172
-300
| -0.2% | -$25.7K |
|
1344
Sinclair Inc
SBGI
$1.03B
| $12.1M | ﹤0.01% |
779,264
-172,293
| -18% | -$3.07M |
|
|
DO
1345
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $12.1M | ﹤0.01% |
1,160,718
+189,002
| +19% | +$1.73M |
|
|
PDCE
1346
DELISTED
PDC Energy, Inc.
PDCE
| $12M | ﹤0.01% |
189,794
-34,158
| -15% | -$2.38M |
|
1347
CarParts.com
PRTS
$54.7M
| $12M | ﹤0.01% |
192,281
+16,456
| +9% | +$862K |
|
1348
Southwest Gas
SWX
$6.67B
| $12M | ﹤0.01% |
194,279
-132,192
| -40% | -$8.99M |
|
1349
Virtus Investment Partners
VRTS
$1.1B
| $12M | ﹤0.01% |
62,733
+4,387
| +8% | +$785K |
|
1350
UMB Financial
UMBF
$11.1B
| $12M | ﹤0.01% |
143,158
-35,512
| -20% | -$2.98M |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.